For example, antisense oligonucleotides (ASOs) are used to target and degrade aberrant mRNAs associated with various neurodegenerative diseases, such as ALS (targeting SOD1 and C9ORF72) (reviewed in [84, 85]). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.